Related Experiment Video
Updated: Jul 16, 2026

Preparation of Naringenin Solution for In Vivo Application
Published on: August 10, 2021
Effects of Opuntia megacantha on blood glucose and kidney function in streptozotocin diabetic rats
P Bwititi1, C T Musabayane, C F Nhachi
1Department of Medical Laboratory Sciences, Faculty of Medicine, University of Zimbabwe, Harare.
Abstract:
The purpose of the study was to investigate the effects of Opuntia megacantha leaf extracts on blood glucose concentrations and kidney function in normal and streptozotocin (STZ)-diabetic rats. STZ-diabetic and non-diabetic rats were orally administered extracts of O. megacantha leaves (20 mg/100 g body weight) daily for 5 weeks and respective control rats were administered normal saline (0.1 ml/100 mg body weight). Urine volume, urinary outputs of Na+, K+ and creatinine were monitored daily over the 5-week period. Plasma concentrations of Na+, K+, urea and creatinine and the glomerular filtration rate (GFR) as assessed by creatinine clearance were determined after 5 weeks. Plasma glucose concentrations in STZ-diabetic and non-diabetic rats were reduced by the administration of leaf extracts of O. megacantha. However, leaf extracts increased urinary Na+ output in STZ-diabetic and non-diabetic rats, concomitantly with a reduction in plasma concentration of the ion. O. megacantha leaf extracts significantly increased plasma creatinine and urea concentrations in non-diabetic and STZ-diabetic rats. Administration of the leaf extract was also associated with an increased GFR in STZ-diabetic rats (from 1.8 +/- 0.3 ml/min to 2.8 +/- 0.3 ml/min, n = 8) although the rate was unaltered in non-diabetic rats. The results suggest that leaf extracts of O. megacantha not only reduce blood glucose levels, but may be toxic to the kidney as shown by the elevation in plasma urea and creatinine concentrations and the reduction of plasma Na+ concentration.
Insights
Opuntia megacantha leaf extracts lowered blood glucose in rats but may harm kidneys. The extracts increased urinary sodium and elevated plasma urea and creatinine, indicating potential kidney toxicity.
Area of Science:
- Pharmacology
- Nephrology
- Diabetology
Background:
- Diabetes mellitus is a metabolic disorder characterized by hyperglycemia.
- Kidney dysfunction is a common complication of diabetes.
- Herbal remedies are explored for managing diabetes and its complications.
Purpose of the Study:
- To investigate the effects of Opuntia megacantha leaf extracts on blood glucose and kidney function.
- To assess the impact of O. megacantha on normal and streptozotocin (STZ)-induced diabetic rats.
Main Methods:
- Rats (normal and STZ-diabetic) were orally administered O. megacantha leaf extracts (20 mg/100 g body weight) or saline daily for 5 weeks.
- Urine volume, urinary Na+, K+, and creatinine output were monitored.
- Plasma Na+, K+, urea, creatinine, and glomerular filtration rate (GFR) were determined.
Main Results:
- O. megacantha leaf extracts reduced plasma glucose concentrations in both normal and STZ-diabetic rats.
- Extracts increased urinary Na+ output and decreased plasma Na+ concentration.
- Significant elevations in plasma creatinine and urea were observed, suggesting kidney impairment.
- GFR increased in STZ-diabetic rats but remained unchanged in normal rats.
Conclusions:
- Opuntia megacantha leaf extracts demonstrate hypoglycemic effects.
- The extracts may possess nephrotoxic properties, evidenced by increased plasma urea and creatinine and decreased plasma sodium.
- Further research is warranted to elucidate the mechanisms and safety profile of O. megacantha for kidney function.
More Related Videos
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Symptoms, Diagnosis, and Complications
Oral Hypoglycemic Agents: Biguanides and Glitazones
Hyperglycemia
Diabetic Nephropathy

